VALOPRA Syrup

Sodium valproate

57.64 mg/ml

ACINO MEA FZ-LLC MIDDLE EAST AFRICA SCIENTFIC OFFICE

Pack size	1 Bottle (150 ml)
Dispensing mode
Source
Agent
Retail Price	11.25 AED

Available as:

200 mg/ml - Solution

Indications

VALOPRA Syrup is used for: This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex sodium is also used to treat the manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches

Adult Dose

Child Dose

Renal Dose

Administration

Contra Indications

Precautions

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Sodium valproate :

Mechanism of Action

Although the mechanism of action of valproate is not fully understood, it has recently been shown to protect against a seizure-induced reduction in phosphatidylinositol (3,4,5)-trisphosphate (pip3) as a potential therapeutic mechanism. In addition, its anticonvulsant effect has been attributed to the blockade of voltage-dependent sodium channels and increased brain levels of gamma-aminobutyric acid (gaba). The gabaergic effect is also believed to contribute towards the anti-manic properties of valproate

Note

VALOPRA 57.64 mg/ml Syrup manufactured by ACINO MEA FZ-LLC MIDDLE EAST AFRICA SCIENTFIC OFFICE. Its generic name is Sodium valproate. VALOPRA is availble in Saudi Arabia. Farmaco SA drug index information on VALOPRA Syrup is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Sodium valproate :

Solution

VALOPRA ^{200 mg/ml}

ACINO MEA FZ-LLC MIDDLE EAST AFRICA SCIENTFIC OFFICE

Powder and Solvent for Solution for Injection

DEPAKINE ^{100 mg/ml}

ALLERGAN INC.

Solution for Injection/Infusion

VALPOHARDT ^{100 mg/ml}

ALFA INTES INDUSTRIA TERAPEUTICA SPLENDORE S.R.L

Syrup

DEPAKINE ^{57.64 mg/ml}

BEXIMCO PHARMACEUTICALS LIMITED

Gastro-resistant Tablet

DEPAKINE ^{500 mg}

ALLERGAN INC.